By |

Equities News

Company chart and information is provided by TradingView based on 15-minute-delayed data.


Profile

Affimed NV is a clinical-stage biopharmaceutical company. The company is engaged in discovering and developing targeted cancer immunotherapies. Its product candidates are being developed in the field of immuno-oncology, which represents an approach to cancer treatment that seeks to harness the body's immune defenses to fight tumor cells. The company is also developing single and combination therapies to treat cancers and other life-threatening diseases. Geographically, it derives a majority of revenue from the United States and also has a presence in Europe and Germany.

Contact Information

Website: www.affimed.com
Email: ir@affimed.com
Main Phone: +49 6221674360
Address: Im Neuenheimer Feld 582
Address 2: Technologiepark
City / Town: Heidelberg
Country: DE
Postal Code: 69120

Issuer Information

Exchange: NSD
CEO: Adi Hoess
Employees: 128
NAICS: Biological Product (except Diagnostic) Manufacturing(325414)

Equities News

(%)
Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume N/A 52 Wk Hi N/A 52 Wk Low N/A
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares N/A EPS (TTM) N/A PE Ratio N/A Exchange N/A